Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinibT D Kim, Phillipp D. Le Coutre, Wilhelm Haverkamp et al.|Leukemia|2013Cited by 233
Differences among young adults, adults and elderly chronic myeloid leukemia patientsFabio Castagnetti, Mariella Girasoli, Gabriele Gugliotta et al.|Annals of Oncology|2014Cited by 99
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patientsMassimo Gentile, Fortunato Morabito, Tait D. Shanafelt et al.|Leukemia|2015Cited by 35
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor modelStefano Molica, Francesca Romana Mauro, Diana Giannarelli et al.|American Journal of Hematology|2022Cited by 10
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O‐<scp>CLL</scp>1‐<scp>GISL</scp> studyMassimo Gentile, Fortunato Morabito, Giovanna Cutrona et al.|European Journal Of Haematology|2015Cited by 9